DR. ULRIKE MARGRET REISS, MD

Plain English
This paper examines a health project in New Caledonia called Do-Kamo, which focuses on putting people first and incorporating cultural perspectives into healthcare. The study highlights how this model could improve health outcomes by addressing the unique needs of the local population. This matters because creating a system that respects cultural beliefs can lead to better care and satisfaction for patients. Who this helps: Patients in New Caledonia and similar communities.

Plain English
This study looked at a new gene therapy called FLT180a to treat patients with hemophilia B, a condition where the blood doesn't clot properly due to low levels of a protein called factor IX. In the trial, 10 patients received different doses of FLT180a, and after six months, all showed improvements in factor IX levels, with five patients achieving normal levels. This is important because it shows that FLT180a could significantly improve blood clotting in hemophilia B patients, potentially reducing the need for regular treatments. Who this helps: Patients with hemophilia B.

Plain English
This study investigated the use of eltrombopag, a medication that boosts blood platelet production, in children with severe aplastic anemia (SAA) who didn't have a matching sibling donor. Out of 25 patients, those who received eltrombopag along with standard treatment had a 71% success rate after 6 months, similar to the 100% success rate in those receiving only standard treatment. Importantly, the addition of eltrombopag was safe, with no major differences in infection rates observed. Who this helps: This research benefits children with severe aplastic anemia and their doctors by providing new treatment options.

Plain English
This study looked at a safer method for treating children with dyskeratosis congenita (DKC) using a reduced-intensity chemotherapy before a bone marrow transplant. Among nine patients treated, most (67%) are still alive after almost six years, and their lung function did not worsen after the procedure. This is important because it shows that this less harsh treatment works well without causing additional lung damage, making it a better option for these vulnerable patients. Who this helps: This benefits children with dyskeratosis congenita and their doctors.

Plain English
This study looked at a young boy who had all the symptoms of Pacak-Zhuang syndrome, a rare condition that can cause too many red blood cells, specific tumors, and problems with his vision. They found a specific genetic change (an EPAS1 mutation) in his tumors, but not in his inherited DNA. Understanding this syndrome is important because it helps identify and manage similar cases in other patients. Who this helps: This helps doctors and pediatric patients with Pacak-Zhuang syndrome.

Plain English
This study focused on finding a gene therapy for haemophilia B, a bleeding disorder caused by a lack of a specific protein called factor IX. Researchers discovered that giving patients a single dose of a specially designed virus can significantly improve their condition. This is important because it offers a new treatment option for those suffering from severe haemophilia B, who currently have very few effective therapies available. Who this helps: Patients with severe haemophilia B and other liver-related genetic disorders.

Plain English
This study looked at the challenges of using genetic information to personalize medication for patients, as new discoveries in genetics are coming quickly but not being put to use effectively. The Pharmacogenomics Research Network found that practical tools and strategies, called "implementation best practices," are needed to help integrate these genetic tests into everyday healthcare. This is important because it can lead to better treatment decisions and improve patient outcomes. Who this helps: Patients who require personalized medication based on their genetic profiles.

Plain English
This study looked at treatments to clear blocked central venous catheters, which are important for patients with long-term health issues. It found that medications like alteplase cleared 52% of blockages in just 30 minutes and had an overall success rate of 86%. Newer treatments like reteplase and tenecteplase showed even better results, with clearance rates up to 95%. This matters because resolving blockages quickly can prevent treatment delays and improve patient care. Who this helps: Patients with chronic illnesses who rely on central venous catheters for their treatment.

Plain English
This study looked at a teenage patient who developed a serious condition called severe aplastic anemia after being treated with a drug called temozolomide for brain cancer. After more than two years without complications from the cancer, the patient underwent a successful bone marrow transplant to treat the anemia. This finding is important because it shows that bone marrow transplantation can effectively address severe blood problems caused by cancer treatments. Who this helps: This helps patients recovering from gliomas who develop severe aplastic anemia due to their treatment.

Plain English
This study looked at problems caused by long-term central venous catheters (CVCs), which are tubes used in patients with chronic illnesses. It found that CVCs often get clogged or can lead to blood clots; treatments can include special drugs to dissolve clots or using specific techniques to fix blockages. Understanding these issues is crucial because untreated complications can lead to serious health problems like infections or even lung clots. Who this helps: This helps patients who need long-term CVCs, as well as doctors managing their care.

Plain English
This study looked at using a combination of low-dose cyclophosphamide and interferon alfa 2a to treat a type of growth called capillary hemangiomas in the eye area of young children. Out of five patients, four showed significant improvement, with their hemangiomas reducing in size by 40% to 60%, which helped alleviate issues with vision and eye discomfort. This treatment approach is important because it offers a way to manage these growths with fewer side effects than traditional long-term treatments. Who this helps: This benefits infants and young children with capillary hemangiomas around the eyes.

Plain English
Researchers studied an enzyme called sphingosine-1-phosphate lyase to see how it affects cell survival during stress. They found that when this enzyme is increased in cells, it leads to higher levels of certain fatty molecules called ceramides, which cause more cell deaths (apoptosis). By boosting this enzyme, cells lost their ability to survive under stress, highlighting its role in controlling cell fate, particularly in conditions like cancer. Who this helps: This helps patients with cancer and their doctors by providing insights for potential new treatments.

Plain English
Researchers looked at 83 children with solid tumors who received stem cell transplants to see how often they developed a liver problem called veno-occlusive disease (VOD). They found that 24% of the patients developed VOD, with those diagnosed with neuroblastoma being much more at risk—6.1 times more likely than those with other tumors. This is important because understanding the high risk in neuroblastoma patients can help doctors better manage their treatment and monitor for complications. Who this helps: This helps doctors and caregivers of children with neuroblastoma.

Plain English
This study looked at venoocclusive disease (VOD) in 241 children and young adults who received blood or bone marrow transplants. It found that VOD developed in 27% of patients, with 20% experiencing severe cases, and those with VOD had a lower survival rate—77% at 100 days compared to 94% for those without VOD. The study highlights the need for early detection and specific treatment for VOD, especially since some patients can recover even from severe cases. Who this helps: This helps patients undergoing blood and bone marrow transplants and their doctors.

Plain English
This study looked at how different methods of hematopoietic cell transplantation (HCT) can improve treatment outcomes for children and adolescents with high-risk blood cancers. Researchers found that using high-dose chemotherapy followed by HCT has led to better results, especially for conditions like acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). They also noted that new techniques, such as using different sources of stem cells and immunotherapy, could further enhance the effectiveness of HCT and reduce side effects from treatment. Who this helps: This helps patients with high-risk blood cancers and healthcare professionals treating them.

Plain English
This study looked at how to prevent a serious complication called graft-versus-host disease (GVHD) in children receiving stem cell transplants from donors who are not perfectly matched. The researchers found that when they reduced the number of T cells in the transplanted cells to below 50,000 per kilogram, there was a much lower chance of developing GVHD. Specifically, among 21 patients evaluated, only five developed moderate to severe GVHD, demonstrating that maintaining low T cell levels (below 50,000) is crucial for safety after these types of transplants. Who this helps: This helps pediatric patients in need of stem cell transplants when matched donors are unavailable.

Plain English
This study looked at the death rates of 441 children and teenagers with chronic kidney problems over 24 years, focusing on the impact of treatments like dialysis and kidney transplants. They found that the overall death rate dropped significantly from 6.6 deaths per 100 patients per year in the early years (1969-1978) to 2.5 in the late '70s and early '80s (1979-1988) but crept back up to 2.9 in the early '90s (1989-1992). Many deaths were linked to serious health issues other than kidney failure, especially after a kidney transplant, where cancer cases became a major concern. Who this helps: This information is valuable for doctors treating young patients with kidney failure and helps families understand risks over time.

Plain English
This study focused on a boy with a rare and severe form of Cockayne syndrome, who faced serious health problems from a young age. He developed kidney issues and high blood pressure, leading to neurological problems and frequent infections; ultimately, he passed away at the age of 6. The findings highlight the critical complications associated with Cockayne syndrome, including kidney failure and adrenal problems, which can significantly impact a child's health and life expectancy. Who this helps: This information helps doctors and families better understand the severe effects of Cockayne syndrome.

Plain English
This study looked at 374 children and teenagers with chronic kidney failure over 20 years to see how their treatment and survival have changed. It found that younger children, especially those under 5, made up a larger percentage of patients, increasing from 21% to 47%. The survival rate for patients on kidney treatments increased significantly, with 77% surviving after 10 years and 100% surviving after 2 years on newer dialysis methods in the latest period. Who this helps: This helps children with chronic kidney failure and their families by improving treatment options and survival rates.

Plain English
This study looked at a hormone called atrial natriuretic peptide (ANP), which affects things like blood pressure and fluid balance in the body. The researchers found that high levels of ANP can indicate conditions like high blood pressure or heart and kidney failure, while lower levels can suggest the opposite. Understanding ANP levels could help doctors make better decisions regarding treatment for these health issues. Who this helps: This helps patients with high blood pressure, heart failure, and kidney problems.

Plain English
This study examined the differences in a protein called maltase found in young and old rats. Researchers discovered that young rats mainly have an active form of maltase, while older rats have more of an inactive version of the protein, which explains why older rats show lower maltase activity. Understanding these changes is important because it sheds light on how aging affects enzyme function, which might lead to better treatments for age-related health issues. Who this helps: This helps researchers and doctors studying aging and age-related diseases.

Plain English
This study looked at how a specific enzyme that helps break down sugars in the kidneys changes as rats age. Researchers found that the activity of this enzyme, maltase, decreased by about 30% in older rats compared to younger ones, which affects how well the enzyme works. This decline seems to be due to changes in the enzyme itself rather than its surrounding environment, which is important because it shows that aging directly impacts kidney function. Who this helps: This benefits patients with kidney issues and their doctors by improving understanding of age-related kidney decline.

Plain English
Researchers studied levels of a hormone called Prostaglandin F2alpha (PGF2alpha) in the blood of women during labor and shortly after childbirth. They found that PGF2alpha levels peaked at the time of delivery, with the highest concentrations measured in the blood from the umbilical cord compared to the mother’s blood. This is important because it shows that PGF2alpha plays a key role in helping the uterus contract and manage the delivery process. Who this helps: This information benefits doctors and healthcare providers supporting women during childbirth.

Plain English
This study looked at how a medication called indomethacin affects levels of a substance called prostaglandin F2alpha in women who are giving birth. Researchers found that after taking indomethacin, the levels of prostaglandin F2alpha dropped significantly within 30 minutes, but the usual rapid changes in these levels during labor stayed the same. This is important because it shows how indomethacin can help manage labor-related pain without fully disrupting the normal process. Who this helps: This benefits women in labor and their healthcare providers.

Plain English
This study looked at how indomethacin, a medication that blocks certain chemicals in the body, affects labor in 16 pregnant women. The results showed that in 8 women, labor completely stopped for anywhere between 3 and 192 hours, while in another 8, the active labor phase was longer than usual, lasting an extra 3 to 17 hours. Out of the 16 women, 7 delivered naturally, but 9 needed additional medication called pitocin to help with contractions. Who this helps: This research benefits doctors and healthcare providers managing labor in pregnant patients.

Plain English
This study examined a specific enzyme from the livers of young and old rats to see how aging affects its performance. The researchers found that the enzyme from older rats had lower activity, was more sensitive to heat, and showed signs of accumulation of certain materials, indicating changes due to aging. These findings are important because they suggest that the reduced function of this enzyme might play a role in the decline of cellular health as animals (and potentially humans) age. Who this helps: This helps researchers and doctors understand age-related changes in enzyme activity that may affect overall health.

Plain English
Researchers studied an enzyme called isocitrate lyase in young and old free-living nematodes, specifically looking at how aging affects its activity. They found that while both young and old nematodes have the same types of this enzyme, the older version works less effectively, showing a significant decline in activity—about 30% less than the younger enzyme. This matters because understanding how enzymes change with age could help develop ways to manage age-related issues in organisms. Who this helps: This helps researchers and scientists studying aging and its effects on cellular functions.

Plain English
This study looked at how certain parts of cells get damaged over time due to a process called lipid peroxidation, which leads to the creation of fluorescent pigments similar to a substance known as lipofuscin. The researchers found that these fluorescent products can be measured using specific wavelengths of light, allowing scientists to identify and quantify the damage caused by lipid peroxidation. Understanding this process is important because it helps us learn about aging and how cells can become less healthy over time. Who this helps: This helps researchers and medical professionals studying aging and cellular health.